Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Use of prasugrel in a patient with clopidogrel hypersensitivity
Sarah R. Peppard
, Bethanne M. Held-Godgluck
, Richard Beddingfield
Anesthesiology
Research output
:
Contribution to journal
›
Article
›
peer-review
16
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Use of prasugrel in a patient with clopidogrel hypersensitivity'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Nursing and Health Professions
Clopidogrel
100%
Erethism
100%
Prasugrel
100%
Ticlopidine
30%
Thienopyridine Derivative
20%
Allergic Reaction
20%
Bare Metal Stent
20%
Percutaneous Coronary Intervention
20%
Coronary Stent
20%
Health Care Quality
10%
Stent
10%
Syndrome
10%
Ticagrelor
10%
ST Segment Elevation Myocardial Infarction
10%
Coronary Artery Disease
10%
Extubation
10%
Desensitization
10%
Stent Thrombosis
10%
Desquamation
10%
Cross Allergy
10%
Warfarin
10%
Cilostazol
10%
Efficacy
10%
Allergy
10%
Keyphrases
Clopidogrel
100%
Prasugrel
100%
Therapeutic Potential
30%
Ticlopidine
30%
Aspirin
20%
Percutaneous Coronary Intervention
20%
Bare Metal Stent
20%
Thienopyridines
20%
Ticagrelor
10%
Warfarin
10%
Desensitization
10%
Hematologic
10%
Potential Treatments
10%
Coronary Artery Disease
10%
Standard of Care
10%
Third Generation
10%
ST-elevation Myocardial Infarction (STEMI)
10%
Young Males
10%
Allergic Reaction
10%
Stent Placement
10%
Extubation
10%
Desquamation
10%
Cilostazol
10%
Cross-sensitivity
10%
Stevens-Johnson Syndrome
10%
Coronary Stent Thrombosis
10%
Coronary Stent Placement
10%
Intolerant
10%
Erythematous Plaques
10%
Pharmacology, Toxicology and Pharmaceutical Science
Clopidogrel
100%
Erethism
100%
Prasugrel
100%
Ticlopidine
30%
Thienopyridine
20%
Acetylsalicylic Acid
20%
Allergic Reaction
20%
Desensitization
10%
Ticagrelor
10%
Syndrome
10%
ST Segment Elevation Myocardial Infarction
10%
Coronary Artery Disease
10%
Desquamation
10%
Stent Thrombosis
10%
Cross Allergy
10%
Warfarin
10%
Cilostazol
10%
Allergy
10%